Procter & Gamble (NYSE:PG – Get Free Report) had its price objective decreased by stock analysts at JPMorgan Chase & Co. from $186.00 to $181.00 in a research note issued to investors on Thursday,Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 13.35% from the company’s current price.
Other research analysts have also recently issued reports about the company. Wells Fargo & Company lowered their price objective on Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Barclays cut shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 target price for the company. in a report on Monday, September 30th. Piper Sandler started coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target for the company. Finally, Evercore ISI lifted their target price on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research report on Monday, October 21st. Eight analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and an average target price of $179.50.
Read Our Latest Stock Report on PG
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. During the same quarter in the previous year, the business posted $1.83 EPS. The firm’s revenue was down .6% on a year-over-year basis. Analysts anticipate that Procter & Gamble will post 6.93 earnings per share for the current fiscal year.
Insiders Place Their Bets
In related news, CEO R. Alexandra Keith sold 1,992 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total transaction of $338,640.00. Following the sale, the chief executive officer now directly owns 13,783 shares in the company, valued at approximately $2,343,110. This trade represents a 12.63 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the sale, the insider now owns 11,566 shares in the company, valued at $1,954,538.34. This represents a 52.53 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 75,439 shares of company stock worth $13,317,460 over the last three months. 0.18% of the stock is owned by insiders.
Institutional Trading of Procter & Gamble
Large investors have recently modified their holdings of the business. Itau Unibanco Holding S.A. acquired a new stake in Procter & Gamble during the 2nd quarter valued at approximately $28,000. RPg Family Wealth Advisory LLC bought a new stake in shares of Procter & Gamble in the 3rd quarter worth about $33,000. Quest Partners LLC acquired a new stake in shares of Procter & Gamble in the 2nd quarter valued at about $36,000. Costello Asset Management INC grew its stake in Procter & Gamble by 2,142.9% in the third quarter. Costello Asset Management INC now owns 314 shares of the company’s stock worth $54,000 after purchasing an additional 300 shares in the last quarter. Finally, William B. Walkup & Associates Inc. bought a new stake in shares of Procter & Gamble in the 2nd quarter valued at approximately $58,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
- Five stocks we like better than Procter & Gamble
- Dividend Capture Strategy: What You Need to Know
- 3 Cheap Small-Cap Banks for Dividend Growth Investors
- Where to Find Earnings Call Transcripts
- 3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year
- What is a Dividend King?
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.